IPCA Laboratories: Emkay Global sees 21% upside; projects 12–13% FY27 sales growth
- Posted on June 3, 2026
- By Financial Express
- 0 Views
- 1 min read
IPCA Laboratories: Emkay Global sees 21% upside; projects 12–13% FY27 sales growth
Emkay Global sees 21% upside for IPCA Labs, fueled by strong earnings and sales growth. Discover why analysts rate it a 'Buy' now!